ArriVent BioPharma, Stock Forecast - Daily Balance Of Power
| AVBP Stock | 27.45 0.86 3.23% |
ArriVent Stock Forecast is based on your current time horizon.
ArriVent |
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| 0.3869 | 0.4322 |
| Check ArriVent BioPharma, Volatility | Backtest ArriVent BioPharma, | Information Ratio |
ArriVent BioPharma, Trading Date Momentum
| On November 25 2024 ArriVent BioPharma, Common was traded for 27.45 at the closing time. The top price for the day was 27.64 and the lowest listed price was 25.65 . There was no trading activity during the period 0.0. Lack of trading volume on November 25, 2024 did not affect price variability. The overall trading delta against the current closing price is 2.81% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
| Compare ArriVent BioPharma, to competition |
Other Forecasting Options for ArriVent BioPharma,
For every potential investor in ArriVent, whether a beginner or expert, ArriVent BioPharma,'s price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ArriVent Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ArriVent. Basic forecasting techniques help filter out the noise by identifying ArriVent BioPharma,'s price trends.ArriVent BioPharma, Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ArriVent BioPharma, stock to make a market-neutral strategy. Peer analysis of ArriVent BioPharma, could also be used in its relative valuation, which is a method of valuing ArriVent BioPharma, by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
ArriVent BioPharma, Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of ArriVent BioPharma,'s price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of ArriVent BioPharma,'s current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
ArriVent BioPharma, Market Strength Events
Market strength indicators help investors to evaluate how ArriVent BioPharma, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ArriVent BioPharma, shares will generate the highest return on investment. By undertsting and applying ArriVent BioPharma, stock market strength indicators, traders can identify ArriVent BioPharma, Common entry and exit signals to maximize returns.
ArriVent BioPharma, Risk Indicators
The analysis of ArriVent BioPharma,'s basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ArriVent BioPharma,'s investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting arrivent stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.72 | |||
| Semi Deviation | 3.87 | |||
| Standard Deviation | 3.68 | |||
| Variance | 13.53 | |||
| Downside Variance | 16.68 | |||
| Semi Variance | 15.01 | |||
| Expected Short fall | (2.77) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with ArriVent BioPharma,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ArriVent BioPharma, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArriVent BioPharma, will appreciate offsetting losses from the drop in the long position's value.Moving against ArriVent Stock
| 0.67 | MTEM | Molecular Templates | PairCorr |
| 0.63 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.59 | TPST | Tempest Therapeutics | PairCorr |
| 0.56 | NKTX | Nkarta Inc | PairCorr |
| 0.55 | ME | 23Andme Holding | PairCorr |
The ability to find closely correlated positions to ArriVent BioPharma, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ArriVent BioPharma, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ArriVent BioPharma, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ArriVent BioPharma, Common to buy it.
The correlation of ArriVent BioPharma, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ArriVent BioPharma, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ArriVent BioPharma, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ArriVent BioPharma, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for ArriVent Stock Analysis
When running ArriVent BioPharma,'s price analysis, check to measure ArriVent BioPharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ArriVent BioPharma, is operating at the current time. Most of ArriVent BioPharma,'s value examination focuses on studying past and present price action to predict the probability of ArriVent BioPharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ArriVent BioPharma,'s price. Additionally, you may evaluate how the addition of ArriVent BioPharma, to your portfolios can decrease your overall portfolio volatility.